RankAlpha logo
Back to Rankings

IPSC

Century TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
IPSC vs peer average
39/100
IPSC vs. peer average (D vs. C)
Grade spread
A 1 · C 3 · D 2 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

GALT is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $353.98M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerGALTGalectin Therapeutics
IPSC
Century Therapeutics
GALT
Galectin Therapeutics
Grade
D
C
Momentum
35
94
Value
41
41
Sentiment
-
54
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs GALT

IPSC / GALT
Grade Position
Below peers
IPSC vs. peer average (D vs. C)
39/100
Momentum
35
GALT
Value
41
IPSC
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs IPSC
1
GALT
Galectin Therapeutics Inc Common
C
60/100
-1
2
CUVL
Clinuvel Pharmaceuticals Ltd ADR
D
40/100
Even
3
DMAC
DiaMedica Therapeutics Inc Common
F
20/100
+1
4
SABS
SAB Biotherapeutics Inc Common
D
40/100
Even
5
SCTX
Scribe Therapeutics Inc Common
C
60/100
-1
GALT is the first peer returned for this comparison set.